We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$23M
2
MDLZ icon
Mondelez International
MDLZ
+$11.8M
3
GIS icon
General Mills
GIS
+$11.6M
4
JNJ icon
Johnson & Johnson
JNJ
+$8.36M
5
CRM icon
Salesforce
CRM
+$5.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Healthcare 15.36%
3 Financials 15.12%
4 Consumer Discretionary 11.34%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITT icon
526
ITT
ITT
$19.1B
$335K 0.02%
5,470
-2,600
-32% -$150K
LPLA icon
527
LPL Financial
LPLA
$28.6B
$330K 0.02%
+5,110
New +$339K
UFS
528
DELISTED
DOMTAR CORPORATION (New)
UFS
$329K 0.02%
6,300
+1,000
+19% +$50.4K
STLD icon
529
Steel Dynamics
STLD
$37.6B
$328K 0.02%
7,250
-13,350
-65% -$615K
AEO icon
530
American Eagle Outfitters
AEO
$3.01B
$325K 0.02%
13,100
+300
+2% +$7.6K
YUMC icon
531
Yum China
YUMC
$16.3B
$323K 0.02%
+9,200
New +$328K
EPR icon
532
EPR Properties
EPR
$4.77B
$321K 0.02%
+4,685
New +$318K
NLY icon
533
Annaly Capital Management
NLY
$17.4B
$319K 0.02%
+7,795
New +$327K
SRPT icon
534
Sarepta Therapeutics
SRPT
$1.77B
$319K 0.02%
+1,975
New +$270K
VMI icon
535
Valmont Industries
VMI
$9.53B
$319K 0.02%
2,300
+200
+10% +$28.1K
SCG
536
DELISTED
Scana
SCG
$319K 0.02%
8,202
+2,300
+39% +$88.2K
CGNX icon
537
Cognex
CGNX
$11.3B
$318K 0.02%
+5,700
New +$292K
HWC icon
538
Hancock Whitney
HWC
$6.24B
$316K 0.02%
6,650
+200
+3% +$10.1K
MDU icon
539
MDU Resources
MDU
$4.32B
$315K 0.02%
32,213
+8,415
+35% +$90K
NXPI icon
540
NXP Semiconductors
NXPI
$60.4B
$315K 0.02%
3,680
+1,800
+96% +$173K
GMED icon
541
Globus Medical
GMED
$11.2B
$312K 0.02%
5,500
-100
-2% -$5.26K
HIW icon
542
Highwoods Properties
HIW
$3.47B
$305K 0.02%
6,450
+1,700
+36% +$83.9K
TMO icon
543
Thermo Fisher Scientific
TMO
$220B
$305K 0.02%
+1,250
New +$288K
EXAS
544
DELISTED
Exact Sciences
EXAS
$304K 0.02%
+3,850
New +$251K
JAZZ icon
545
Jazz Pharmaceuticals
JAZZ
$16.7B
$303K 0.02%
+1,800
New +$310K
NUS icon
546
Nu Skin
NUS
$267M
$297K 0.02%
+3,600
New +$286K
SVC
547
Service Properties Trust
SVC
$1.07B
$295K 0.02%
2,044
+520
+34% +$74.5K
BHF icon
548
Brighthouse Financial
BHF
$3.5B
$294K 0.02%
+6,644
New +$280K
LPX icon
549
Louisiana-Pacific
LPX
$5.49B
$293K 0.02%
11,050
-100
-0.9% -$2.85K
TDS icon
550
Telephone and Data Systems
TDS
$3.75B
$293K 0.02%
9,620
+1,600
+20% +$45.7K
20 21
22
23 24

Similar funds

MF
MHI Funds Woodstock, New York $34.7M AUM 17.93% 1-Year Est. Return
AIM
Act II Management New York $33.8M AUM 8.86% 1-Year Est. Return
QCMA
Quad Capital Management Advisors New York $31.4M AUM 22.55% 1-Year Est. Return
SC
Salzman & Co Pittsford, New York $29.7M AUM 12.12% 1-Year Est. Return
BIM
Beach Investment Management West Conshohocken, Pennsylvania $28.8M AUM 11.57% 1-Year Est. Return
GP
Gresham Partners Chicago, Illinois $26.2M AUM 18.05% 1-Year Est. Return
GAM
GQ Asset Management New York City, New York $52.7M AUM 8.84% 1-Year Est. Return
SCM
Shoals Capital Management Arlington, Virginia $21.5M AUM 38.8% 1-Year Est. Return

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.